BGP advises the shareholders of PharmaSwiss AG
01. February 2011
Bader Gnehm & Partner, Attorneys-at-law, advised the shareholders of PharmaSwiss Ltd. regarding the sale of PfarmaSwiss Ltd. for EUR 350 million to Valeant Pharmaceuticals International, Inc.